GGS
TNYA icon

Galvin Gaustad & Stein’s Tenaya Therapeutics TNYA Stock Holding History

Galvin Gaustad & Stein’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.62K Hold
11,000
– – ﹤0.01% 252
2025
Q4 		$7.83K Hold
11,000
– – ﹤0.01% 250
2025
Q3 		$17.8K Hold
11,000
– – ﹤0.01% 206
2025
Q2 		$6.72K Buy
+11,000
New +$5.6K ﹤0.01% 191

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Galvin Gaustad & Stein's TNYA Position: Q1 2026 in Review

Galvin Gaustad & Stein held its Tenaya Therapeutics (TNYA) position steady in Q1 2026 at 11,000 shares worth $7.62K. The position accounts for ﹤0.01% of the portfolio, ranked #252.

Galvin Gaustad & Stein first reported a position in TNYA in Q2 2025 and has held it in 4 quarters since. The position peaked at $17.8K in Q3 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Galvin Gaustad & Stein held 11,000 shares of Tenaya Therapeutics worth $7.62K as of Q1 2026.
  • Galvin Gaustad & Stein left its Tenaya Therapeutics share count unchanged in Q1 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Galvin Gaustad & Stein's portfolio in Q1 2026, its #252 holding.
  • Galvin Gaustad & Stein first reported a position in Tenaya Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Galvin Gaustad & Stein's Tenaya Therapeutics position peaked at $17.8K in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Galvin Gaustad & Stein's 13F filing for Q1 2026, filed 14 May 2026.